IQVIA Holdings reported $7.78B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Accenture USD 22.3B 695.27M Jun/2026
Agilent USD 2.29B 20M Jun/2026
Bruker USD 1.17B 32.6M Sep/2026
Cardinal Health USD 46.33B 2.42B Sep/2026
Celltrion KRW 288.01B 4.7B Jun/2026
Charles River Laboratories USD 1.09B 45.49M Sep/2026
Cigna USD 56.03B 471M Sep/2026
Cognizant Technology Solutions USD 3.64B 174M Sep/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
CVS Health USD 93.1B 6.06B Sep/2026
Danaher USD 9.05B 945M Sep/2026
Dentsply International USD 1.22B 32M Sep/2026
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 28.51M 5.87M Sep/2026
Divis Laboratories Ltd INR 27.07B 6.64B Sep/2026
Elevance Health USD 46.66B 2.41B Sep/2026
Humana USD 24.05B 1.05B Sep/2026
IBM USD 36.48B 573M Sep/2026
Illumina USD 1.16B 422M Sep/2026
Infosys INR 535.81B 528.47B Sep/2026
Kangmei Pharma CNY 5.1B 280.48M Jun/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Laboratory Of America USD 2.82B 695M Sep/2026
Malin Corporation EUR 1000K 500K Dec/2024
McKesson USD 74.4B 4.04B Sep/2026
Mettler Toledo International USD 1.25B 49.81M Sep/2026
Organigram Holdings CAD 107.28M 18.54M Jun/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pharma Mar EUR 125.39M 26.97M Sep/2026
Publicis EUR 23.94B 47M Jun/2026
Qiagen NV USD 581.45M 102.34M Jun/2026
Quest Diagnostics USD 1.83B 46M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
Sartorius EUR 1.55B 102.8M Sep/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Tilray USD 259.32M 8.32M Sep/2025
UnitedHealth USD 115.84B 4.02B Sep/2026
Veeva Systems USD 1.46B 245.82M Jun/2026
Veradigm USD 230.31M 22.78M Dec/2022
Waters USD 2.4B 126M Jun/2026
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.74B 277.02M Sep/2026